CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE On Demand Web ArchiveNon-Accredited Target Audience: Physicians, nurses, and technologists. This activity is supported by an educational grant from Terumo Medical Corporation. |
10th Biennial Meeting
Purpose and Overview
Introduction to the Proceedings from the
10th Biennial Meeting of the
International Andreas Gruentzig Society
held January 25–31 in Cape Town, South Africa
From its beginnings at the first gathering at the University of Alabama at Birmingham in 1990, the International Andreas Gruentzig Society (IAGS) has brought together cardiovascular specialists from around the world to honor Andreas Gruentzig and continue the spirit of his innovation that led to the development of coronary angioplasty in the mid 1970’s. Over the years, the attendees of this meeting have expanded to include not only interventional cardiologists, but also interventional radiologists, vascular surgeons, neurovascular interventionists, and leaders from the device and pharmaceutical industry. The meetings have continued in the tradition of open forum, forward thinking collaborations among the attendees. Over the years each meeting has had its unique focus, but the overriding theme has been to delve into the challenges faced in advancing the diagnosis and treatment of cardiovascular disease. Participants are encouraged to identify the critical challenges that exist and formulate potential solutions. Often the discussions at IAGS meetings have been a precursor to significant advances in the field, including the use of stents and the emerging role of genetics in fashioning customized therapy.
The Journal of Invasive Cardiology is the official journal of the society and has published the proceedings of the meetings over the last 20 years. The most recent meeting in South Africa covered many critical areas of cardiovascular medicine. Over the next few months, the leaders of each of these sections are going to provide an overview of their topic and a summary of the major discussions that occurred at the meeting. We hope to create a dialogue between the session leader and the readership of the journal to extend the discussions beyond what occurred at the South Africa meeting. I encourage you to actively engage in these discussions and participate in the expansion of the goal of the IAGS – to continue the innovative spirit of Andreas Gruentzig in advancing the field of cardiovascular medicine.
Richard E. Shaw, PhD, FACC, FACA
Editor-in-Chief
The Journal of Invasive Cardiology
Cardiology Blogs
All Subscriptions are FREE to qualified cardiology professionals

- Subscribe to:
- Journal
- Digital Journal
- E-News
- RSS feed
Anytown, California
Press Release
— Bethlehem, Pennsylvania – Invatec received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October to market its Mo.Ma Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS). The device effectively reduces and captures debris released during the stenting procedure to prevent it from traveling to the brain, where it has the potential to cause a stroke.
CME Showcase
![]() The Use of Remote Robotic Navigation in Complex Arrhythmias Complimentary Accredited Web Archive This activity is designed for electrophysiologists and EP allied professionals. Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions New Standards of Care for CRMD Antibiotic Protection Complimentary CME Accredited Webcast Dates: November 18, 2008 Time: 6:00 pm ET November 19, 2008 Time: 3:00 pm ET This activity is sponsored by the North American Center for Continuing Medical Education. |























Post new comment